{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:36:59Z","timestamp":1777102619325,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.01.047","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T11:54:13Z","timestamp":1454414053000},"page":"1611-1616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Adverse events following immunization in patients with primary immunodeficiencies"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-6489","authenticated-orcid":false,"given":"Juan David","family":"Sarmiento","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Villada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio Cesar","family":"Orrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5664-6415","authenticated-orcid":false,"given":"Jose Luis","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia M.","family":"Trujillo-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.01.047_bib0195","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS phenotypic classification for primary immunodeficiencies","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0200","series-title":"Immunization Safety Surveillance. Guidelines for Managers of Immunization Programmes on Reporting and Investigating Adverse Events Following Immunization","author":"Mansoor","year":"1999"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0205","first-page":"5791","article-title":"Algorithm to assess causality after individual adverse events following immunizations","volume":"30","author":"Halsey","year":"2012"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.047_bib0210","first-page":"83","article-title":"BCGiosis as a presenting feature of a child with chronic granulomatous disease","volume":"15","author":"Movahedi","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0215","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1684-1182(10)60082-5","article-title":"Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies","volume":"43","author":"Santos","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.047_bib0220","first-page":"328","article-title":"Disseminated BCG as a unique feature of an infant with severe combined immunodeficiency","volume":"53","author":"Norouzi","year":"2011","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0225","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/j.ijid.2009.02.008","article-title":"Disseminated bacille Calmette-Guerin in Iranian children with severe combined immunodeficiency","volume":"13","author":"Sadeghi-Shabestari","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0230","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.0736-8046.2004.21606.x","article-title":"Lymphadenopathy after BCG vaccination in a child with chronic granulomatous disease","volume":"21","author":"Vieira","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1525-1470.2001.018003205.x","article-title":"Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature","volume":"18","author":"Antaya","year":"2001","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.047_bib0240","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1651-2227.1998.tb01535.x","article-title":"Disseminated Bacillus Calmette-Guerin infection in a girl with hyperimmunoglobulin E syndrome","volume":"87","author":"Pasic","year":"1998","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaci.2007.04.034","article-title":"BCG-osis and tuberculosis in a child with chronic granulomatous disease","volume":"120","author":"Bustamante","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.047_bib0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7774\/cevr.2015.4.2.195","article-title":"Adverse reactions to Mycobacterium bovis bacille Calmette-Guerin vaccination against tuberculosis in Iranian children","volume":"4","author":"Mahmoudi","year":"2015","journal-title":"Clin Exp Vaccine Res"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2016.01.047_bib0255","first-page":"S259","article-title":"Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency","volume":"24","author":"Sohail","year":"2014","journal-title":"J Coll Physicians Surg Pak"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.047_bib0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4067\/S0716-10182014000400010","article-title":"Bacillus Calmette-Guerin (BCG) disease and interleukin 12 receptor beta1 deficiency: clinical experience of two familial and one sporadic case","volume":"31","author":"Strickler","year":"2014","journal-title":"Rev Chil Infectol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.047_bib0265","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0270","unstructured":"Vaccines in primary immunodeficiencies patients. Arch Argent Pediatr 2010; 108(5): 454\u201364."},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.047_bib0275","first-page":"413e1","article-title":"Consensus document by the Spanish Society of Paediatric Infectious Diseases","volume":"75","author":"Mellado Pena","year":"2011","journal-title":"An Pediatr (Barc)"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.047_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.047_bib0285","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","article-title":"Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0290","unstructured":"P\u00fablica GISdVyCeS. Informe de eventos supuestamente atribuidos a la vacunaci\u00f3n o inmunizaci\u00f3n; hasta el periodo epidemiol\u00f3gico XIII del a\u00f1o 2012. Available from: \u3008http:\/\/www.ins.gov.co:81\/lineas-de-accion\/Subdireccion-Vigilancia\/Informe%20de%20Evento%20Epidemiolgico\/ESAVI%202012.pdf?Mobile=1&Source=%2Flineas-de-accion%2FSubdireccion-Vigilancia%2F_layouts%2Fmobile%2Fmblwp.aspx%3FUrl%3D%252FLINEAS-DE-ACCION%252FSUBDIRECCION-VIGILANCIA%252FPaginas%252Finformes-de-evento.aspx%26CurrentPage%3D1\u3009."},{"key":"10.1016\/j.vaccine.2016.01.047_bib0295","unstructured":"Social MdSyp. Programa Ampliado de Inmunizaciones (PAI). Available from: \u3008https:\/\/www.minsalud.gov.co\/salud\/publica\/Vacunacion\/Paginas\/pai.aspx\u3009."},{"key":"10.1016\/j.vaccine.2016.01.047_bib0300","unstructured":"Colombia MdlPS, Salud OPdl. Cruzada interminable por la ni\u00f1ez colombiana. Historia del Programa Ampliado de Inmunizaciones - PAI -En Colombia. 1979\u20132009. Available from: \u3008https:\/\/www.minsalud.gov.co\/Documentos%20y%20Publicaciones\/CRUZADA%20INTERMINABLE%20POR%20LA%20NI%C3%91EZ%20COLOMBIANA.pdf\u3009."},{"key":"10.1016\/j.vaccine.2016.01.047_bib0305","first-page":"6920","article-title":"Overview of the clinical consult case review of adverse events following immunization: clinical Immunization Safety Assessment (CISA) network 2004\u20132009","volume":"29","author":"Williams","year":"2011"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.047_bib0310","first-page":"202","article-title":"Mycobacterium bovis dissemination (BCG strain) among immunodeficient Brazilian infants","volume":"6","author":"Jacob","year":"1996","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"30","key":"10.1016\/j.vaccine.2016.01.047_bib0315","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/j.vaccine.2014.05.022","article-title":"Vaccine use in primary immunodeficiency disorders","volume":"32","author":"Principi","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.047_bib0320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/cei.12421","article-title":"Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray","volume":"178","author":"Bayer","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.047_bib0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12026-014-8485-4","article-title":"An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia","volume":"60","author":"Modell","year":"2014","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.047_bib0330","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","article-title":"Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT","volume":"112","author":"Le Saux","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.2009-1496","article-title":"Lack of association between acellular pertussis vaccine and seizures in early childhood","volume":"126","author":"Huang","year":"2010","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.047_bib0340","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0387-7604(03)00169-4","article-title":"An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines","volume":"26","author":"Geier","year":"2004","journal-title":"Brain Dev"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.047_bib0345","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"issue":"36","key":"10.1016\/j.vaccine.2016.01.047_bib0350","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1016\/j.vaccine.2012.06.017","article-title":"The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh","volume":"30","author":"Sazzad","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2016.01.047_bib0355","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3855\/jidc.2372","article-title":"Isolation of poliovirus shedding following vaccination in children with antibody deficiency disorders","volume":"6","author":"Galal","year":"2012","journal-title":"J Infect Dev Ctries"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.047_bib0360","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00431-008-0674-5","article-title":"Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis","volume":"167","author":"Mamishi","year":"2008","journal-title":"Eur J Pediatr"},{"issue":"12","key":"10.1016\/j.vaccine.2016.01.047_bib0365","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1086\/379791","article-title":"Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis","volume":"188","author":"Khetsuriani","year":"2003","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.047_bib0370","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/08820139.2013.859156","article-title":"Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature","volume":"43","author":"Shaghaghi","year":"2014","journal-title":"Immunol Investig"},{"issue":"7","key":"10.1016\/j.vaccine.2016.01.047_bib0375","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3201\/eid1607.091606","article-title":"Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995\u20132008","volume":"16","author":"Shahmahmoodi","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.047_bib0380","first-page":"3255","article-title":"Safety reporting in developing country vaccine clinical trials\u2014a systematic review","volume":"30","author":"Muehlhans","year":"2012"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T16:22:56Z","timestamp":1537028576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16000992"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events following immunization in patients with primary immunodeficiencies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}